Allison Luo
Director Técnico/Científico/I+D en PROMETHEUS BIOSCIENCES, INC. .
Cargos activos de Allison Luo
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
PROMETHEUS BIOSCIENCES, INC. | Director Técnico/Científico/I+D | 01/08/2018 | - |
BIORA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2017 | - |
Historial de carrera de Allison Luo
Antiguos cargos conocidos de Allison Luo.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Director/Miembro de la Junta | 01/09/2006 | 01/10/2014 |
IVERIC BIO, INC. | Corporate Officer/Principal | 01/09/2015 | - |
ABBOTT LABORATORIES | Director Técnico/Científico/I+D | - | - |
Formación de Allison Luo.
Northwestern University | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 2 |
Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
ABBOTT LABORATORIES | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
BIORA THERAPEUTICS, INC. | Health Services |
Empresas privadas | 2 |
---|---|
Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
IVERIC bio, Inc.
IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Allison Luo
- Experiencia